News archive
EASD 2024 – MADRID [SEPTEMBER 9-13]
PILA PHARMA will participate in the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD) of Diabetes. The company is excited to meet with peers in the metabolic space to learn about the newest scientific developments and discuss how PILA PHARMA’s unique and potential first-in-class TRPV1-antagonist could offer a beneficial new drug for patients.
PILA PHARMA will be represented by Founder, Chairman & CSO Dorte X. Gram as well as CEO Gustav H. Gram
Thursday August 29: Redeye Investor Forum [ONLINE] 14:00 CET
CEO Gustav H. Gram will present the company and its half year report and give introduction to its unique treatment for obesity & type 2 diabetes, the market and the overall investment case
Wednesday August 28: Aktiespararna Life Science Day [ONLINE] 20:00 CET
CEO Gustav H. Gram will present the company and its unique treatment for obesity & type 2 diabetes
June 27th-30th, 2024
PILA PHARMA will present the hypothesis of targeting the “chili-receptor”, TRPV1 in metabolic disorders.
BIO International Convention
San Diego, US: Monday to Thursday, 3-6 June 2024
Thursday May 22
Redeye Theme: Diabetes
Online: Thursday 24 May 2024 at 9:30 CET
Wednesday April 17
Aktiespararna Lifescience Day [Online] 15:45 CET
Presentation with ‘Aktiespararna’ at their annual Lifescience Day on the outlook of Pila Pharma in a global diabetes and obesity context.
Dansk Aktionærforening Fyn [INVESTOR DAGEN] (Odense, Denmark)
Tuesday, 16 April 2024 from 15:00 CET
Redeye Online Investor Event (ONLINE / Stockholm, Sweden)
Thursday, 11 April 2024 from 14:00 CET
Dansk Aktionærforening Vestegnen (Vallensbæk, Denmark)
Hør Pila Pharma fortælle om deres historie og projekter inden for diabetes og fedmemedicin hos Dansk Aktionærforening på Vestegnen.
(26 March-2024)
AktieInfo Danmark – Sydhavnen (Copenhagen S, Denmark)
(21 March-2024)
Business conference to meet with Swiss investors and engage in partnership discussions with Swiss pharma companies.
Swiss-Nordic BIO (Zürich, Switzerland)
(7 March-2024)
Mød stifter og CEO, Dorte X. Gram, der fortæller om den spæde start som PhD på Novo Nordisk hvor opfindelsen fandt sted, de lovende studier og planerne for 2024.
Dansk Aktionærforening Trekant (Kolding, Denmark)
(4 March-2024)
Earnings call with comments on 2023, and outlook on 2024 with CEO Dorte X. Gram
Submit questions beforehand and sign up via this link. Stokk.io (ONLINE EVENT)
(28 February-2024)
